Responses
Oral Presentations
Abstract session: SLE and Sjögren's: new treatment options
OP0185 Significant Clinical Improvement and Reduction of Severe Flares Following Administration of an IL-6 Monoclonal Antibody in Systemic Lupus Erythematosus (SLE) Subjects with High Disease Activity
Compose a Response to This Article
Other responses
No responses have been published for this article.